Navigation Links
Grifols Celebrates Initial Construction of New IVIG Facility with Los Angeles Officials and Dignitaries
Date:1/13/2009

Grifols welcomes Los Angeles Mayor Antonio Villaraigosa, Cal State LA President James Rosser, Councilman Hose Huizar, patient representatives and other dignitaries for the construction dedication ceremony of its new IVIG facility.

LOS ANGELES, Jan. 13 /PRNewswire/ -- Today, Grifols SA (Grifols), a global healthcare company based in Barcelona, Spain, Grifols welcomes Los Angeles Mayor Antonio Villaraigosa., Cal State LA President James Rosser, Councilman Jose Huizar and other elected officials, patient representatives and dignitaries for the ceremonial dedication of its new IVIG facility. Grifols, a global healthcare company based in Barcelona, Spain, recently broke ground on a new 92,000 square foot, intravenous immune globulin (IVIG) production facility at its US headquarters in East Los Angeles. This new facility is the initial realization of its $600 million long-range investment plan announced in October 2007 to increase production for Grifols lifesaving therapies.

The new facility represents a $135 million investment in its facility in El Sereno and will provide approximately 300 new high-paying jobs to Los Angeles. "We are committed to growing Grifols operations in Los Angeles and to giving back to the community through the creation of new quality jobs and economic growth" said Gregory Rich, President of Grifols, Inc.

"Without the support of Mayor Villaraigosa and his business team, we would not have been able to make our vision a reality in Los Angeles. This is the first step in our long-range growth plans for Los Angeles and to meet increasing patient needs for lifesaving plasma therapies."

"The bio-med industry is a critical component of the economic engine of Los Angeles and I am pleased to support Grifols expansion and investment in our great city. As the bio-med sector continues to grow, it will provide good, high-wage jobs for Angelinos. I am glad that we were instrumental in supporting Grifols expansion and allowing them to double their production capacity for their lifesaving therapies" said Mayor Antonio R. Villaraigosa.

"We commend Grifols' increased commitment to the production of immune globulin therapy. Assuring continued access to this lifesaving medicine means countless people who live with primary immunodeficiencies, such as my son, can lead healthy and productive lives," said Marcia Boyle, President and Founder of the Immune Deficiency Foundation, the national patient organization for persons with primary immune diseases.

Demand for IVIG has seen steady growth over the past ten years in the US, Europe and other international markets. The dedication ceremony took place at Grifols' US production campus and US corporate offices at 2410 Lillyvale, Los Angeles on Tuesday, January 13, 2009 at 11:00 a.m. This unique event brought together elected officials, representatives from national patient organizations, and Grifols officials to celebrate the company's efforts to ensure continued access to life-saving plasma medicines including IVIG.

About Grifols

Grifols SA (Grifols) is a global healthcare company founded in 1940 in Barcelona, Spain. Today Grifols products and services are provided in more than 90 countries around the world. Grifols specializes in the production of plasma therapies to treat a variety of life-threatening diseases and conditions. Grifols operates 80 plasma donor centers throughout the US and has manufacturing facilities located in Barcelona, Spain and Los Angeles, California. For more information about Grifols please visit www.grifols.com or contact:


'/>"/>
SOURCE Grifols SA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Grifols Biomat USA Opens New Plasma Donor Center in Lincoln
2. Coalition for Pulmonary Fibrosis Celebrates Landmark Year for Awareness, Advocacy, Research
3. Glaucoma Research Foundation Celebrates National Glaucoma Awareness Month
4. Cystic Fibrosis Services Pharmacy Celebrates 20th Anniversary
5. Mental Health America Celebrates 100 Years of Mental Health Advocacy and Support
6. Retired Heart Surgeon Dr. Dwight Lundell Celebrates 65th Birthday by Placing First in Arizona Ironman Competition
7. Cloned Canine Celebrates Her 1st Birthday
8. Blue Shield of California Celebrates Completion of New Lodi Campus
9. Tenegar Town Celebrates Dedication Of New Clinic As Beacon Of Hope
10. Florida's Natural Celebrates 75 Years with Record Performance
11. Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: